Ulcerative colitis occurring in the course of rheumatoid arthritis: A case successfully treated with mesalamine enema

Internal Medicine

Volumn 43, Issue 11, 2004, Pages 1046-1050

  Sugisaki, Kota ^a   Honma, Fumiko ^a   Iwadate, Haruyo ^a   Shio, Kiori ^a   Shioya, Yasuo ^a   Fukaya, Etsuko ^a   Sato, Kaoru ^a   Saito, Hiroyuki ^a   Sekine, Hideharu ^a   Kobayashi, Hiroko ^a   Orikasa, Hiroshi ^a   Watanabe, Hiroshi ^a   Sato, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Mesalamine enema; Rheumatoid arthritis; Ulcerative colitis

Indexed keywords

DICLOFENAC; ENEMA; FOSFOMYCIN; LORNOXICAM; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; CRYPT CELL; DISEASE COURSE; FEMALE; FEVER; GOBLET CELL; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; NEUTROPHIL CHEMOTAXIS; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; ENEMA; FEMALE; HUMANS; MESALAMINE; TREATMENT OUTCOME;

EID: 10244229790     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.1046     Document Type: Article

References (26)

1. Aoyanagi T, Nakajima H, Ozaki M, et al. Inflammatory bowel disease and extra bowel lesions. Naika 66: 1068-1071, 1990 (in Japanese).
2. Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Q J Med 72: 835-840, 1989.
3. Adachi Y, Hinoda Y, Takahashi H, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol 31: 590-595, 1996.
4. Klausen T, Amris K, Helin P. Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis. Ann Rheum Dis 51: 1009-1011, 1992.
5. Kohriyama K, Hiramatsu Y, Nishizaki H, Kirizuka K. Uncommon cases of ulcerative colitis associated with polyarthritis. A review of the literature. Rinsho Ryumachi 12: 275-282, 2000 (in Japanese, Abstract in English).
6. Mosquera-Martinez JA. Rheumatoid arthritis associated with ulcerative colitis. Ann Rheum Dis 60: 1155, 2001.
7. Boyer F, Fontanges E, Miossec P. Rheumatoid arthritis associated with ulcerative colitis: a case with severe flare of both diseases after delivery. Ann Rheum Dis 60: 901, 2001.
8. Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 234: 29-40, 2001.
9. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6: 205-214, 2000.
10. Teodorescu V, Bauer J, Lichtiger S, Chapman M. Gold-induced colitis: a case report and review of the literature. Mt Sinai J Med 60 238-241, 1993.
11. Langer HE, Hartmann G, Heinemann G, Richter K. Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature. Ann Rheum Dis 46: 787-792, 1987.
12. Fam AG, Paton TW, Sharness CJ, Lewis AJ. Fulminant colitis complicating gold therapy. J Rheumatol 7: 479-485, 1980.
13. Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93: 480-489, 1987.
14. Soussi F, Tchirikhtchian K, Ramaholimihaso F, et al. Diclofenac-induced colitis complicated by Klebsiella oxytoca infection. Gastroenterol Clin Biol 25: 814-816, 2001 (in French, Abstract in English).
15. Baert F, Hart J, Blackstone MO. A case of diclofenac-induced colitis with focal granulomatous change. Am J Gastroenterol 90: 1871-1873, 1995.
16. Kam L, Cohen H, Dooley C, Rubin P, Orchard J. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Am J Gastroenterol 91: 1338-1342, 1996.
17. Andreoli A, Spinella S, Levenstein S, Prantera C. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Ital J Gastroenterol 26: 121-125, 1994.
18. McPhee MS, Swan JT, Biddle WL, Greenberger NJ. Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas. Dig Dis Sci 32: 76S-81S, 1987.
19. Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ, May RJ. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Am J Gastroenterol 81: 412-418, 1986.
20. Malchow H, Gertz B, CLAFOAM Study Group. A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. Aliment Pharmacol Ther 16: 415-423, 2002.
21. Campieri M, Paoluzi P, D'Albasio G, Brunetti G, Pera A, Barbara L. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. Dig Dis Sci 38: 1843-1850, 1993.
22. Tokui K, Asai Y, Arakawa T, Matsumoto T, Nabeshima T. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers. Biol Pharm Bull 25: 264-267, 2002.
23. Otten MH, De Haas G, Van den Ende R. Colonic spread of 5-ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. Aliment Pharmacol Ther 11: 693-697, 1997.
24. Bondesen S, Nielsen OH, Jacobsen O, et al. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. Scand J Gastroenterol 19: 677-682, 1984.
25. Neumann VC, Taggart AJ, Le Gallez P, Astbury C, Hill J, Bird HA. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 13: 285-287, 1986.
26. Volin MV, Campbell PL, Connors MA, Woodruff DC, Koch AE. The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production. Exp Mol Pathol 73: 84-92, 2002.